Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -16.28% is 48% above its 5-year average of -31.42%, near the high end of its 5-year range (-79.65%–-13.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 63.98% above its 12-month average of -45.20%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -16.28%.
RETURN ON INVESTED CAPITAL (ROIC)
-16.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-45.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-21.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-31.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+63.98%
CURRENT VS 3Y AVG
+24.74%
CURRENT VS 5Y AVG
+48.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 603 covered companies
CURRENT VS SECTOR MEDIAN
+53.18%
vs the sector median at left
LENSAR Inc
Market Cap
$81.55M
Return on Invested Capital (ROIC)
-16.28%
TTM Avg
-45.20%
3Y Avg
-21.63%
5Y Avg
-31.42%
Market Cap
$81.82M
Return on Invested Capital (ROIC)
-88.72%
TTM Avg
-42.77%
3Y Avg
-39.33%
5Y Avg
-39.33%
Market Cap
$82.18M
Return on Invested Capital (ROIC)
-88.28%
TTM Avg
-61.59%
3Y Avg
-48.92%
5Y Avg
-67.61%
Market Cap
$82.45M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-27.86%
3Y Avg
-23.01%
5Y Avg
-20.58%
Market Cap
$79.62M
Return on Invested Capital (ROIC)
-48.39%
TTM Avg
-44.64%
3Y Avg
-40.56%
5Y Avg
-32.79%
Market Cap
$84.39M
Return on Invested Capital (ROIC)
-90.27%
TTM Avg
-103.33%
3Y Avg
-85.38%
5Y Avg
-72.83%
Market Cap
$85.01M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
Market Cap
$78.42M
Return on Invested Capital (ROIC)
-836.58%
TTM Avg
-213.85%
3Y Avg
-158.30%
5Y Avg
-121.35%
Market Cap
$85.17M
Return on Invested Capital (ROIC)
-159.30%
TTM Avg
-82.85%
3Y Avg
-66.58%
5Y Avg
-50.22%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LENSAR Inc (LNSR) | $81.55M | -16.28% | -45.20% | -21.63% | -31.42% |
| Citius Oncology, Inc. (CTOR)vs › | $81.82M | -88.72% | -42.77% | -39.33% | -39.33% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.18M | -88.28% | -61.59% | -48.92% | -67.61% |
| MediciNova, Inc. (MNOV)vs › | $82.45M | -31.62% | -27.86% | -23.01% | -20.58% |
| Pulmonx Corporation (LUNG)vs › | $79.62M | -48.39% | -44.64% | -40.56% | -32.79% |
| Humacyte, Inc. (HUMA)vs › | $84.39M | -90.27% | -103.33% | -85.38% | -72.83% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.01M | -109.43% | -208.02% | -178.83% | -203.50% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.42M | -836.58% | -213.85% | -158.30% | -121.35% |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.17M | -159.30% | -82.85% | -66.58% | -50.22% |
| Nutriband Inc. (NTRB)vs › | $85.25M | -126.99% | -110.63% | -85.52% | -67.36% |
ROIC
-16.3%
ROE
232.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -16.28% |
| 2026-03-31 | -33.63% |
| 2025-12-31 | -79.65% |
| 2025-09-30 | -60.76% |
| 2025-06-30 | -35.67% |
| 2025-03-31 | -21.06% |
| 2024-12-31 | -13.07% |
| 2024-09-30 | -16.64% |
| 2024-06-30 | -18.42% |
| 2024-03-31 | -19.25% |
| 2023-12-31 | -21.10% |
| 2023-09-30 | -19.85% |
| 2023-06-30 | -22.96% |
| 2023-03-31 | -42.54% |
| 2022-12-31 | -45.42% |
| 2022-09-30 | -47.71% |
| 2022-06-30 | -49.62% |
| 2022-03-31 | -40.23% |
| 2021-12-31 | -34.03% |
| 2021-09-30 | -37.60% |
| 2021-06-30 | -32.64% |
| 2021-03-31 | -30.47% |
| 2020-12-31 | -26.19% |
| 2020-09-30 | -18.75% |
| 2020-06-30 | -44.65% |
| 2019-12-31 | -47.61% |
